Literature DB >> 3538345

Enzyme immunoassay of complement-binding rheumatoid factors.

A M Teppo, C P Maury.   

Abstract

We describe an enzyme immunoassay for the determination of complement-binding rheumatoid factors. Polystyrene tubes are coated with heat aggregated human IgG. The rheumatoid factors (RFs) of patients heat inactivated sera are allowed to bind to aggregated IgG and thereafter saturated with fresh human complement. The amount of C3 complement bound is measured by indirect enzyme immunoassay. The levels of complement binding RFs were measured in 30 patients with seropositive rheumatoid arthritis (RA), in 19 patients with systemic lupus erythematosus (SLE), and in 30 healthy control subjects. Compared to the controls high levels of complement-binding RFs were found both in RA and in SLE (P less than 0.0005). The mean level of the complement binding RFs was higher (P less than 0.05) in active than in inactive SLE. Even though the 19 S IgM RF bound complement, in RA no correlation was found between the level of complement binding RFs and Waaler-Rose titre, but the level of complement binding RF correlated with the levels of nonagglutinating IgM RF (r = 0.56, P less than 0.01) and IgG RF (r = 0.70, P less than 0.001) that were obtained by enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538345     DOI: 10.1007/BF00270662

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions.

Authors:  J L Abruzzo; R Heimer
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103

2.  Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor.

Authors:  J T Tesar; F R Schmid
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

3.  The Clq receptor site on immunoglobulin G.

Authors:  D R Burton; J Boyd; A D Brampton; S B Easterbrook-Smith; E J Emanuel; J Novotny; T W Rademacher; M R van Schravendijk; M J Sternberg; R A Dwek
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

4.  Enzyme immunoassay of antibodies to Sjögren's syndrome B antigen.

Authors:  A M Teppo
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

5.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.

Authors:  O Wager; P Lindstrøm
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

7.  Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus.

Authors:  W K Bolton; J H Schrock; J S Davis
Journal:  Arthritis Rheum       Date:  1982-03

8.  The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.

Authors:  R E March; J S Reeback; E J Holborow; V E Jones; R K Jacoby
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease.

Authors:  C Jakle; D W Feigal; D L Robbins; R Shapiro; K Wiesner
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

10.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.